Literature DB >> 12066200

Expression of p73 gene, cell proliferation and apoptosis in breast cancer: Immunohistochemical and clinicopathological study.

Tatsuyoshi Yamamoto1, Koji Oda, Tomoyuki Kubota, Kou Miyazaki, Yasushi Takenouti, Yuji Nimura, Michinari Hamaguchi, Satoru Matsuda.   

Abstract

p73 is a member of p53 tumor suppressor protein family. In spite of similarities of three meaningful domains between p53 and p73, the exact function of p73 protein is not established. To approach the relevance of p73 expression to a pathological parameter in human breast cancer, the apoptotic index (AI) and the mitotic index (MI) were examined for 75 patients with the breast cancer after mastectomies. We found that both of the AI and MI in p73-positive cases were significantly higher compared to the p73-negative cases, suggesting that the p73-positive cases in the breast cancer were in advanced grade. In six cases of breast cancer with distant metastasis, however, the p73 expression was slight and showing low AI but high MI. Advanced breast cancer with distant metastasis seemed to lose the p73 expression and gain the function of evading apoptosis. Altogether, these data demonstrate that p73 expression is well correlated with AI in breast cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12066200

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  5 in total

1.  p73alpha is a candidate effector in the p53 independent apoptosis pathway of cisplatin damaged primary murine colonocytes.

Authors:  A Oniscu; N Sphyris; R G Morris; S Bader; D J Harrison
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

2.  Significance of apoptosis in metastasizing testis tumors.

Authors:  M Abend; M Port; H U Schmelz; K Kraft; C Sparwasser
Journal:  Urol Res       Date:  2003-10-25

3.  Effects of gossypol on apoptosis‑related gene expression in racially distinct triple‑negative breast cancer cells.

Authors:  Samia S Messeha; Najla O Zarmouh; Patricia Mendonca; Hayfaa Alwagdani; Carolyn Cotton; Karam F A Soliman
Journal:  Oncol Rep       Date:  2019-05-31       Impact factor: 3.906

4.  TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer.

Authors:  Utpal K Mukhopadhyay; Chetan C Oturkar; Christina Adams; Nadi Wickramasekera; Sanjay Bansal; Rajesh Medisetty; Austin Miller; Wendy M Swetzig; Laxmi Silwal-Pandit; Anne-Lise Børresen-Dale; Chad J Creighton; Jun Hyoung Park; Santhi D Konduri; Alka Mukhopadhyay; Alexander Caradori; Angela Omilian; Wiam Bshara; Benny Abraham Kaipparettu; Gokul M Das
Journal:  J Natl Cancer Inst       Date:  2019-11-01       Impact factor: 11.816

5.  p53 inactivation upregulates p73 expression through E2F-1 mediated transcription.

Authors:  Chaitali Tophkhane; Shi-He Yang; Yunbo Jiang; Zhikun Ma; Dharmalingam Subramaniam; Shrikant Anant; Shingo Yogosawa; Toshiyuki Sakai; Wan-Guo Liu; Susan Edgerton; Ann Thor; Xiaohe Yang
Journal:  PLoS One       Date:  2012-08-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.